462 related articles for article (PubMed ID: 12444994)
41. Left thoracoabdominal approach for adenocarcinoma of the esophagogastric junction.
Nakamura T; Oguma H; Sasagawa T; Ota M; Kitamura Y; Yamamoto M
Hepatogastroenterology; 2008; 55(85):1332-7. PubMed ID: 18795683
[TBL] [Abstract][Full Text] [Related]
42. Adenocarcinoma of the gastric cardia. The choice of gastrectomy.
Papachristou DN; Fortner JG
Ann Surg; 1980 Jul; 192(1):58-64. PubMed ID: 7406565
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
44. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
45. Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.
Fontana E; Smyth EC; Cunningham D; Rao S; Watkins D; Allum WH; Thompson J; Waddell T; Peckitt C; Chau I; Starling N
Gastric Cancer; 2016 Oct; 19(4):1114-1124. PubMed ID: 26541768
[TBL] [Abstract][Full Text] [Related]
46. Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
Oh SE; Lee GH; An JY; Lee JH; Sohn TS; Bae JM; Kim S; Choi MG
Eur J Surg Oncol; 2022 Feb; 48(2):370-376. PubMed ID: 34433514
[TBL] [Abstract][Full Text] [Related]
47. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
Moesta KT; Hünerbein M; Schlag PM
Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
[No Abstract] [Full Text] [Related]
48. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.
Kurokawa Y; Sasako M; Sano T; Yoshikawa T; Iwasaki Y; Nashimoto A; Ito S; Kurita A; Mizusawa J; Nakamura K;
Br J Surg; 2015 Mar; 102(4):341-8. PubMed ID: 25605628
[TBL] [Abstract][Full Text] [Related]
49. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
[TBL] [Abstract][Full Text] [Related]
50. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
[TBL] [Abstract][Full Text] [Related]
51. Surgical management of gastroesophageal junction tumors.
Amenabar A; Hoppo T; Jobe BA
Semin Radiat Oncol; 2013 Jan; 23(1):16-23. PubMed ID: 23207043
[TBL] [Abstract][Full Text] [Related]
52. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
53. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
[TBL] [Abstract][Full Text] [Related]
54. Surgical treatment of the adenocarcinoma of the cardia.
Celiku E; Draçini X; Dibra A; Maturo A
G Chir; 2011; 32(8-9):353-6. PubMed ID: 22018254
[TBL] [Abstract][Full Text] [Related]
55. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
56. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution.
Kodera Y; Yamamura Y; Shimizu Y; Torii A; Hirai T; Yasui K; Morimoto T; Kato T
J Am Coll Surg; 1999 Dec; 189(6):594-601. PubMed ID: 10589596
[TBL] [Abstract][Full Text] [Related]
57. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification.
Chung JW; Lee GH; Choi KS; Kim DH; Jung KW; Song HJ; Choi KD; Jung HY; Kim JH; Yook JH; Kim BS; Jang SJ
Dis Esophagus; 2009; 22(8):676-81. PubMed ID: 19222529
[TBL] [Abstract][Full Text] [Related]
58. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
[TBL] [Abstract][Full Text] [Related]
59. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
[TBL] [Abstract][Full Text] [Related]
60. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma?
Ichikura T; Ogawa T; Kawabata T; Chochi K; Sugasawa H; Mochizuki H
World J Surg; 2003 Mar; 27(3):334-8. PubMed ID: 12607062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
